Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07808086) titled 'Role of Tumor Microbiota in the Response to Neoadjuvant Therapy in Patients Affected by Triple Negative Breast Cancer' on Sept. 3.
Study Type: Observational
Primary Sponsor: Istituti Clinici Scientifici Maugeri SpA
Condition:
Breast Cancer
Recruitment Status: Recruiting
Date of First Enrollment: September 1, 2026
Target Sample Size: 30
Countries of Recruitment:
Italy
To know more, visit https://clinicaltrials.gov/study/NCT07808086
Published by HT Digital Content Services with permission from Health Daily Digest....